Pravastatin Sodium
NDC Package 24689-143-01

11-digit billing NDC: 24689014301 · Billing unit: EA · 90 EA per package

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Pravastatin Sodium is tablets is indicated: • To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). Marketed by Apnar Pharma Lp, this product is identified by NDC 24689-143 and is authorized under FDA application ANDA077491.

Identification & Billing

NDC Package Code
24689-143-01
Package Description
90 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
24689014301
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA

Clinical Specifications

Proprietary Name
Pravastatin Sodium
Dosage Form
-
Usage Information
Pravastatin sodium tablets is indicated: • To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). • To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD. • As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia. • As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia. o Hypertriglyceridemia.

Regulatory & Marketing

Labeler Name
Apnar Pharma Lp
FDA Application #
ANDA077491
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-15-2024
End Marketing Date
05-10-2026
Listing Expiration
05-10-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24689-143-01 identifies a specific commercial package of 90 tablet in 1 bottle of Pravastatin Sodium, labeled by Apnar Pharma Lp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Apnar Pharma Lp on July 15, 2024. The current certification is valid through May 10, 2026.

How is this Apnar Pharma Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24689014301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24689-143-01
11-Digit CMS (5-4-2)
24689-0143-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.